Humanin represents a founding member of the mitochondrial-derived peptide family, transcribed from a short open reading frame within the 16S ribosomal RNA gene. This comprehensive research guide provides laboratory investigators with an in-depth technical overview of its primary sequence, receptor interactions, intracellular signaling pathways, and experimental parameters. Supplied strictly as a research-grade compound for in vitro and laboratory investigation, Humanin continues to serve as a critical tool for elucidating mitochondrial-nuclear cross-talk and cytoprotective cascades.
Humanin represents a founding member of the mitochondrial-derived peptide family, transcribed from a short open reading frame within the 16S ribosomal RNA gene. This comprehensive research guide provides laboratory investigators with an in-depth technical overview of its primary sequence, receptor interactions, intracellular signaling pathways, and experimental parameters. Supplied strictly as a research-grade compound for in vitro and laboratory investigation, Humanin continues to serve as a critical tool for elucidating mitochondrial-nuclear cross-talk and cytoprotective cascades.
Humanin (HN) was originally identified through functional expression screening of cDNA libraries derived from surviving neuronal tissue in model systems. Unlike conventional nuclear-encoded signaling molecules, Humanin is encoded within the mitochondrial genome—specifically inside the open reading frame (ORF) of the 16S ribosomal RNA (rRNA) gene. This discovery established a paradigm shift in cell biology, proving that the mitochondrial genome encodes small functional microproteins in addition to structural rRNAs, tRNAs, and electron transport chain subunits.
The standard endogenous Humanin polypeptide consists of 24 amino acids (MAPRGFSCLLLLTSEIDLPVKRRA). Biochemical characterization reveals an amphipathic alpha-helical core that mediates membrane interaction and receptor binding. In laboratory settings, synthetic analogs such as S14G-Humanin (HNG), where glycine replaces serine at position 14, are frequently evaluated alongside wild-type Humanin due to enhanced neuroprotective potencies reported in preclinical assays. Research laboratories interested in exploring mitochondrial signaling can reference our broader research library hub for underlying genomic datasets.
Because mitochondrial translation mechanisms utilize non-canonical codon mappings, the recombinant expression and chemical synthesis of mitochondrial-derived peptides present distinct analytical requirements. Automated solid-phase peptide synthesis (SPPS) remains the primary method for producing high-purity Humanin for controlled laboratory experimentation.
Preclinical studies indicate that Humanin exerts its biological actions through both cell-surface receptor complexes and direct intracellular protein-protein interactions. At the extracellular membrane, Humanin acts as an agonist for two distinct receptor classes: the G-protein coupled formyl peptide receptor-like 1 (FPRL1 / FPR2) and a heterotrimeric receptor complex composed of ciliary neurotrophic factor receptor (CNTFR), interleukin 27 receptor subunit alpha (WSX-1), and glycoprotein 130 (gp130).
Binding to the tripartite CNTFR/WSX-1/gp130 complex triggers receptor dimerization and activates the Janus kinase 2 (JAK2) pathway, leading to downstream phosphorylation of Signal Transducer and Activator of Transcription 3 (STAT3). Phosphorylated STAT3 homodimerizes and translocates to the nucleus, where it regulates transcription of genes involved in cell survival and antioxidant defense mechanisms. In vitro experiments demonstrate that blockades of STAT3 phosphorylation abrogate Humanin-mediated cytoprotection.
Intracellularly, Humanin directly binds pro-apoptotic proteins of the Bcl-2 family, notably Bax (Bcl-2-associated X protein) and Bid. In vitro binding assays reveal that Humanin sequesters Bax in the cytosol, preventing its conformational activation, oligomerization, and insertion into the outer mitochondrial membrane. By inhibiting Bax-mediated outer membrane permeabilization, Humanin preserves mitochondrial membrane potential (ΔΨm) and prevents cytochrome c release in challenged cell lines.
In cell culture models of oxidative stress, treatment with research-grade Humanin attenuates reactive oxygen species (ROS) accumulation and reduces lipid peroxidation. Cell types evaluated in vitro include primary cortical neurons, microvascular endothelial cells, cardiomyocytes, and pancreatic beta-cell lines. In these assays, investigators induce metabolic challenge via hydrogen peroxide, tunicamycin (endoplasmic reticulum stress), or serum deprivation, using Humanin as an experimental cytoprotective control.
Animal study models utilizing rodent paradigms of ischemic injury and metabolic dysregulation further illustrate Humanin's broad activity profile. Preclinical rodent models subjected to middle cerebral artery occlusion (MCAO) or myocardial ischemia-reperfusion exhibit reductions in infarct volume upon administration of synthetic Humanin analogs. Furthermore, research indicates that circulating Humanin levels correlate with systemic insulin sensitivity, prompting ongoing investigations into its metabolic influence on peripheral target tissues.
To purchase high-purity material for cellular stress assays, researchers can order Humanin 10mg directly through our verified catalog. For high-throughput laboratory screening requiring larger quantities, PX1 Research provides custom institutional support through our dedicated wholesale program.
Humanin belongs to an expanding class of mitochondrial-derived peptides (MDPs) that coordinate cellular homeostasis, metabolic signaling, and stress responses. To design rigorous comparative studies, researchers frequently evaluate Humanin alongside other key mitochondrial and cytoprotective compounds. The table and detailed analysis below illustrate the distinct genomic origins, primary receptor pathways, and primary focus areas across these structural classes.
While Humanin is encoded within the 16S rRNA gene and acts predominantly through the FPRL1 and CNTFR/WSX-1/gp130 cell-surface receptors to block Bax activation, the MOTS-c peptide is encoded within the 12S rRNA gene and functions primarily as a metabolic regulator that translocates to the nucleus under metabolic stress to bind ARE-containing promoters. In contrast, non-MDP cytoprotective agents like the synthetic tetrapeptide SS-31 cardiolipin protector do not rely on gene transcription; SS-31 targets inner mitochondrial membrane lipids directly, optimizing electron transport chain efficiency. Meanwhile, regulatory peptides like those featured in our Epitalon research guide govern nuclear chromatin remodeling and telomerase expression, illustrating the diverse pathways researchers manipulate when studying cellular aging and survival models.
Achieving consistent results in laboratory assays requires precise reconstitution and handling protocols. Humanin contains hydrophobic residues within its central domain (positions 5–12: F-S-C-L-L-L-L-T), which can induce aggregation if dissolved incorrectly or subjected to repeated freeze-thaw cycles. Lyophilized Humanin should be brought to room temperature in a desiccator prior to opening to avoid moisture condensation.
Reconstitution should ideally be performed using sterile, deionized water or low-ionic-strength phosphate-buffered saline (PBS, pH 7.4). If dissolution proves difficult at higher concentrations (>1 mg/mL), brief gentle vortexing followed by pulse sonication is recommended. Avoid aggressive agitation, which introduces shear stress and promotes fibrillar aggregation. Reconstituted stock solutions should be aliquoted into single-use polypropylene microcentrifuge tubes and stored at -80°C to maintain biological activity.
When planning in vitro concentration curves, typical working concentrations for cell culture models range from 0.1 µM to 10 µM, depending on the severity of the oxidative or apoptotic stimulus. Researchers utilizing alternative MDP formulations alongside Humanin may consult our MOTS-c product listing for comparative handling parameters.
Due to the structural sensitivity of microproteins, verifying compound purity and identity is essential for reproducible research. Substandard synthesis can lead to truncated sequences, deletion peptides, or residual counter-ions (such as trifluoroacetate, TFA) that interfere with sensitive cellular assays and receptor binding kinetics.
PX1 Research subjects every production lot to comprehensive high-performance liquid chromatography (HPLC) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS) analysis. Reverse-phase HPLC ensures a chemical purity threshold of ≥98%, ensuring that peak area integration reflects a homogenous peptide product. Mass spectrometry confirms exact molecular mass matching the theoretical target value of 2687.2 Da for native Humanin.
Additionally, because Humanin is frequently evaluated in cell culture models sensitive to bacterial contamination, endotoxin testing is mandatory. Endotoxin levels are measured via Limulus Amebocyte Lysate (LAL) assays to guarantee values below strict preclinical research thresholds (<0.05 EU/mg). Every shipment includes a lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited laboratory.
PX1 Research operates strictly as a USA-based supplier of research chemicals intended exclusively for laboratory, in vitro, and preclinical investigation. All peptide compounds are synthesized in state-of-the-art, GMP-compliant facilities within the United States. We maintain centralized distribution hubs in California and Arizona to guarantee rapid, temperature-controlled transit to academic and commercial research laboratories.
Orders placed Monday through Friday before cut-off times qualify for same-day dispatch, minimizing ambient exposure and preserving peptide integrity. By upholding transparent analytical testing, rigorous cold-chain logistics, and strict non-human use parameters, PX1 Research serves as a trusted supply partner for advanced biomedical research.
What is the primary origin of Humanin in biological systems?
Humanin is a mitochondrial-derived peptide (MDP) encoded within an open reading frame (ORF) of the 16S ribosomal RNA gene inside the mitochondrial genome.
What receptors does Humanin interact with in cell culture models?
Preclinical data show Humanin binds to the cell-surface G-protein coupled receptor FPRL1 (FPR2) as well as a heterotrimeric receptor complex consisting of CNTFR, WSX-1, and gp130, activating the STAT3 signaling pathway.
Is Humanin approved for human therapeutic use or clinical administration?
No. Humanin is supplied by PX1 Research strictly as a research peptide for in vitro experiments, cell culture assays, and preclinical laboratory study. It is not for human consumption, therapeutic, or clinical use.
How should lyophilized Humanin be stored upon receipt?
Lyophilized Humanin powder should be stored at -20°C or -80°C in a dry, dark environment. Upon reconstitution, single-use aliquots should be frozen at -80°C to avoid degradation from freeze-thaw cycles.
What analytical methods verify the purity of PX1 Research Humanin?
Every lot undergoes Reverse-Phase HPLC to confirm ≥98% purity, Mass Spectrometry (MS) to verify molecular weight, and LAL assays to ensure low endotoxin levels (<0.05 EU/mg). Certificates of Analysis (COAs) are provided for each batch.
What is the difference between native Humanin and S14G-Humanin (HNG)?
S14G-Humanin is a synthetic analog featuring a single amino acid substitution (serine to glycine at position 14) that significantly increases its binding potency in preclinical cytoprotection models compared to wild-type Humanin.
How does Humanin inhibit intracellular apoptotic pathways?
Intracellularly, Humanin directly binds and sequesters the pro-apoptotic protein Bax, preventing its translocation to the outer mitochondrial membrane and halting the activation of the intrinsic apoptotic cascade.
What solubilization diluent is recommended for reconstituting Humanin?
Humanin should be reconstituted using sterile deionized water or low-salinity phosphate-buffered saline (PBS, pH 7.4). Avoid high-salt buffers during initial dissolution to prevent peptide aggregation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.